Clinical trial
Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children…
NCT00463476 · PATH, Other · Completed
Key facts
| NCT number | NCT00463476 |
|---|---|
| Title | Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine |
| Official title | Assessment of the Immunogenicity and Safety of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine in Children in Sri Lanka |
| Lead sponsor | PATH, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Japanese Encephalitis |
| Intervention type | Biological |
| Interventions | Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV) |
| Enrollment | 305 |
| Start date | Jul 9, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Oct 2, 2008 |
| First posted | Apr 20, 2007 |
| Last update posted | Mar 31, 2020 |
| Countries | Sri Lanka |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: